Related News
Merck to build Jiangsu pharmaceutical plant to manufacture 3 drugs
Online Edition
GERMANY-BASED Merck, a leading company in the pharmaceutical and chemical sectors, will spend 650 million yuan (US$104.84 million) in Nantong, Jiangsu Province, to build a new pharmaceutical plant next month, Merck officials said in Shanghai today.
The plant will start operating in 2017 and produce only three medicines - all of them included on the basic medicine list covered by China's medical insurance. The three medicines treat hypertension, diabetes and thyroid disorder.
Merck is the first multinational company to invest heavily in a new plant specifically to produce medicines covered by China's medical insurance.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
